Rapid Micro Biosystems第四季度每股收益$(0.22)优于预期$(0.23),销售额$822万超预期$780万

财报速递
28 Feb
Rapid Micro Biosystems (NASDAQ:RPID)报告季度每股亏损$(0.22),优于分析师普遍预期的$(0.23),增长了4.35%。这相比去年同期每股亏损$(0.26)增加了15.38%。公司报告季度销售额为822万美元,超出分析师普遍预期的780万美元,增长了5.36%。这比去年同期634万美元的销售额增长了29.68%。

以上内容来自Benzinga Earnings专栏,原文如下:

Rapid Micro Biosystems (NASDAQ:RPID) reported quarterly losses of $(0.22) per share which beat the analyst consensus estimate of $(0.23) by 4.35 percent. This is a 15.38 percent increase over losses of $(0.26) per share from the same period last year. The company reported quarterly sales of $8.22 million which beat the analyst consensus estimate of $7.80 million by 5.36 percent. This is a 29.68 percent increase over sales of $6.34 million the same period last year.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10